Please join us for this 1-hour webinar to hear about important safety considerations of using ENFit™ syringes.

Keliana O’Mara, PharmD, BCPS, NICU Clinical Pharmacy Specialist, and Kathy Gomeshi, PharmD, MBA, BCPS, CPPS Medication Safety Officer, UCSF Medical Center, will discuss research findings that indicate a need for increased scrutiny of ENFit syringes.
Maureen Burger, Visante CNO, will moderate the discussion.

Need your assistance if you have experience with a similar case. Abiraterone as a hazardous medication, and a medication of low solubility, with increased absorption with food and consequently increased side effects/adverse events, should not be crushed. We have a patient on NGT and need your guidance on what can be done in this case
Your urgent response is appreciated
Thank you

WE DILUTED THE PHENYLEPHRINE 10 % single dose vial minims in the iso5 aseptic room how many hours can we put the BUD it is written on the phenylephrine box discard the unused portion but it contains sodium metabisulphite as preservative agent

Hello,

Our institution has been having issues with which weight is being used for titratable infusions in EPIC. For institutions that have EPIC, which weight is assigned for titratable infusions? If a dosing weight is used, who is responsible for inputting that weight in the flowsheet (i.e. nursing or pharmacy)?

We especially run into discrepancies when our heparin infusion orders are modified and the current weight is automatically assigned instead of the original weight that the nurse was previously using and programming into the smart pump.

Hello!

Does your organization have an age or weight limit for which you would NOT reconstitute IM ceftriaxone with lidocaine?

If you have restrictions in place, are they the same in both the inpatient and outpatient/ambulatory settings? How do you enforce any established practices (policy, pharmacy, CPOE, etc.)?

Any commentary or experience would be much appreciated! Thanks in advance!
Emily

What is the maximum number of unit dose oral liquid packages (syringes, cups) that your organization would dispense from pharmacy subsequent to a patient order? In this scenario, the nurse would pool the multiple packages into a single oral syringe or cup for patient administration (vs. pharmacy pooling and sending the dose patient-specific).

For example, would you dispense 6x ibuprofen 100 mg/5 mL cups to fulfil a 600 mg order?

Appreciate your feedback!

There is a lot of information out there regarding Federal requirements for documentation of vaccines (lot#, expiration date, Mnfr name, etc), but I am having a hard time finding anything about Immune Globulins. Is documentation of those products similarly regulated by federal agency? What information does your institution documents, upon administration of Varicella, hepatitis, Rabies IGs? Any information/reference is much appreciated.

We have been keen on implementing BCMA in anesthesia for over a year, but have been running into resistance from end users.

I wanted to conduct a short survey to gather data to see if it can help us move further.

1. Have you implemented BCMA in anesthesia/procedure area in your institution?

2. If yes, which EMR do you use?

3. Did you face any barriers from end users? If yes, how did you overcome them?

This will help us greatly if you could answer these questions.

Thank you,
Vaishali

Dears Medication Safety Officers
we noticed that some prescribes are missus STAT orders or they are miss-understanding the differences between STAT, NOW and one dose.
As result i want to see if you have clear definitions with time frames.

Are sites light protecting TPNs for neonates and children <2 yrs given the recent recommendations from the European Medicines Agency? If yes, do you light protect the IV line in addition to the bag?

Or are some institutions waiting until ASPEN releases their position paper?